Stifel Financial Corp Selecta Biosciences Inc Transaction History

Stifel Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$1.83 - $4.06 $19,947 - $44,253	-10,900 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$1.5 - $4.52 $9,000 - $27,119	-6,000 Reduced 35.5%	10,900 $26,000
Q4 2019 Feb 13, 2020	BUY	$1.32 - $2.47 $6,600 - $12,350	5,000 Added 42.02%	16,900 $40,000
Q3 2019 Nov 13, 2019	SELL	$1.6 - $2.08 $3,840 - $4,992	-2,400 Reduced 16.78%	11,900 $21,000
Q2 2019 Aug 14, 2019	SELL	$1.79 - $3.05 $17,255 - $29,402	-9,640 Reduced 40.27%	14,300 $26,000
Q1 2019 May 14, 2019	BUY	$1.47 - $3.06 $35,191 - $73,256	23,940 New	23,940 $55,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.